✦ LIBER ✦

Co-amplification of theHER2gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer

✍ Scribed by Zsuzsanna Varga; Raymond R. Tubbs; Zhen Wang; Yang Sun; Aurelia Noske; Doris Kradolfer; Giovanna Bosshard; Wolfram Jochum; Holger Moch; Christian Öhlschlegel

Book ID: 113062277
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 502 KB
Volume: 132
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1642-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HER2 status in early breast cancer: Rele

HER2 status in early breast cancer: Relevance of cell staining patterns, gene amplification and polysomy 17

✍ Rosalba Torrisi; Nicole Rotmensz; Vincenzo Bagnardi; Giuseppe Viale; Barbara Del 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 150 KB

545 POSTER Possible participation of fra

545 POSTER Possible participation of fragile sites in her2/neu gene amplification on 17q12–21 chromosome in breast cancer

✍ N.Y. Matsenko; S.P. Kovalenko 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Loss of heterozygosity at chromosome 17p

Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer

✍ Evgeny N. Imyanitov; Oleg I. Chernitsa; Irina F. Nikiforova 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 703 KB

## Abstract Sixty DNA samples from breast carcinoma (BC) patients were analyzed by Southern blot to examine certain oncogene and anti‐oncogene alterations. Amplification of the HER‐2 oncogene was detected in 15 tumours (25%), c‐myc in 2 (3%) only and HER‐1 in none. Distribution of Hras‐1 oncogene a

PP52 Amplification of the chromosome 17

PP52 Amplification of the chromosome 17 q22 amplicon containing TOP2A gene is correlated with better survival in HER2 amplified/hormone receptors negative breast cancers

✍ P.-J. Lamy; F. Fina; A.-C. Servanton; C. Dussert; L'H. Ouafik; W. Jacot; P.-M. M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Lack of independent prognostic and predi

Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status

✍ Kirsten Vang Nielsen; Bent Ejlertsen; Susanne Møller; Maj-Britt Jensen; Eva Bals 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 510 KB

Quantification and clinical relevance of

Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers

✍ Pierre-Jean Lamy; Frédéric Fina; Caroline Bascoul-Mollevi; Anne-Claire Laberenne 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 407 KB